Glow Therapeutics

Glow Therapeutics is a science-led medtech company tackling one of dementia’s toughest challenges, sundowning.

Late-day confusion, anxiety, and agitation often force families into costly and premature residential care averaging over £7,000 per month in the UK and $7,000 in the USA.

Our first product, Harmoni, offers a new path. At ~£200, this non-pharmaceutical device uses precise photobiology to gently rebalance neurological rhythms, easing sundowning symptoms and extending the time people can remain at home. The result is better quality of life and thousands saved every month.

Developed with researchers, engineers, and care partners, Harmoni is safe, ergonomic, affordable, and grounded in robust science. Early collaborations show life-changing results, with a global launch planned for late 2025.

We’ve put together an exceptional team and advisory board to bring non-drug dementia care to the mainstream. If you’re a carer, investor, partner, or innovator who sees both the societal need and the commercial opportunity, we’d love to talk.